29875-07-8 Usage
Uses
Used in Pharmaceutical Industry:
4-METHYLBENZYLMAGNESIUM CHLORIDE is used as a key reagent for the synthesis of various pharmaceuticals, contributing to the formation of complex molecular structures through Grignard reactions. Its ability to form carbon-carbon bonds is essential for creating the backbone of many medicinal compounds.
Used in Agrochemical Industry:
In the agrochemical industry, 4-METHYLBENZYLMAGNESIUM CHLORIDE is utilized as a reagent in the synthesis of agrochemicals, such as pesticides and herbicides. Its role in forming carbon-carbon bonds is vital for constructing the active ingredients of these products, which are designed to protect crops and enhance agricultural yields.
Used in Fine Chemicals Industry:
4-METHYLBENZYLMAGNESIUM CHLORIDE is employed as a versatile reagent in the synthesis of fine chemicals, which are high-purity chemicals used in various applications, including fragrances, dyes, and specialty chemicals. Its contribution to the formation of carbon-carbon bonds is crucial for creating the intricate molecular structures required in these high-value products.
Used in Organic Synthesis Research:
4-METHYLBENZYLMAGNESIUM CHLORIDE is used as a research tool in organic synthesis, enabling chemists to explore new reaction pathways and develop innovative synthetic methods. Its reactivity and ability to form carbon-carbon bonds make it an indispensable component in the advancement of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 29875-07-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,8,7 and 5 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 29875-07:
(7*2)+(6*9)+(5*8)+(4*7)+(3*5)+(2*0)+(1*7)=158
158 % 10 = 8
So 29875-07-8 is a valid CAS Registry Number.
InChI:InChI=1/C8H9.ClH.Mg/c1-7-3-5-8(2)6-4-7;;/h3-6H,1H2,2H3;1H;/q-1;;+2/p-1
29875-07-8Relevant articles and documents
Syntheses of 7-Substituted Anthra[2,3- b]thiophene Derivatives and Naphtho[2,3- b:6,7- b']dithiophene
Al-Jumaili, Mustafa A.,Woodward, Simon
, p. 11437 - 11445 (2018/09/06)
7-R-Anthra[2,3-b]thiophene derivatives (1, R = H, Me, i-Pr, or MeO) are prepared in three steps (in average overall yield >50%) starting from (E)-4-RC6H4CH2(HOCH2)C=CI(CH2OH). The latter are commercial or readily prepared from 2-butyne-1,4-diol and ArCH2Cl (both costing 1 cent/mmol) at 10 g scales. These allow for the selective formation of (otherwise unattainable) higher solubility 7-derivatives. Similar methods allow for the preparation of naphtho[2,3-b:6,7-b']dithiophene 2 using equally low-cost starting materials.
HETEROCYCLIC COMPOUND DERIVATIVES AND MEDICINES
-
Page 29, (2010/02/05)
The present invention provides a compound which is useful as a PGI2 receptor agonist, and a pharmaceutical composition. The present invention is directed to a pharmaceutical composition comprising a compound represented by the following formula [1]: (R1 and R2 are the same or different and each represents optionally substituted aryl, Y represents N or CH, Z represents N or CH, A represents NH, NR5, O, S, or ethylene, R5 represents alkyl, D represents alkylene or alkenylene, E represents phenylene or single bond, G represents O, S, or CH2, R3 and R4 are the same or different and each represents hydrogen or alkyl, Q represents carboxy, alkoxycarbonyl, tetrazolyl, carbamoyl, or N-(alkylsulfonyl)carbamoyl), or a pharmaceutically acceptable salt thereof as an active ingredient.
